Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.

Saved in:

Bibliographic Details
Title:	Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.
Authors:	Compter I; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Eekers DBP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Hoeben A; Department of Medical Oncology, GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Rouschop KMA; Department of Radiotherapy, GROW School for Oncology, Maastricht University, Maastricht, The Netherlands., Reymen B; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Ackermans L; Department of Neurosurgery, Maastricht University Medical Centre+, Maastricht, The Netherlands., Beckervordersantforth J; Department of Pathology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Bauer NJC; Department of Ophthalmology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Anten MM; Department of Neurology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Wesseling P; Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Postma AA; Department of Radiology and Nuclear Medicine, School for Mental Health and Sciences, Maastricht University Medical Centre+, Maastricht University Medical Center, Maastricht, The Netherlands., De Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Lambin P; Department of Radiology and Nuclear Medicine, School for Mental Health and Sciences, Maastricht University Medical Centre+, Maastricht University Medical Center, Maastricht, The Netherlands.; The D-Lab & the M-lab, Dpt of Precision Medicine, GROW - School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Source:	Autophagy [Autophagy] 2021 Sep; Vol. 17 (9), pp. 2604-2612. Date of Electronic Publication: 2020 Sep 20.
Publication Type:	Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101265188 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8635 (Electronic) Linking ISSN: 15548627 NLM ISO Abbreviation: Autophagy Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1554-8635
DOI:	10.1080/15548627.2020.1816343